Le Lézard
Classified in: Health
Subjects: RCL, CFG

Advisory - Multiple cold and flu powdered medications, for adults and children 12 years of age and older, recalled due to potential health risks


OTTAWA, ON, Dec. 20, 2021 /CNW/ -

Summary

Issue

CellChem Pharmaceuticals Inc. is recalling all lots of cold and flu medications, sold in pouches of dissolvable powder, due to potential health risks. The products are authorized for use in adults and children 12 years of age and older. They are available over-the-counter and sold under various generic store-brand labels at many retailers across Canada.

The products are being recalled because the company could not demonstrate that products remain safe and of good quality until the expiry date. In addition, multiple lots had active ingredients, such as acetaminophen, that were not in the amounts listed on the product label.  

Products that contain less than the labelled quantity of active ingredients may be less effective. Taking products that contain more than the labelled quantity of active ingredients can lead to inadvertently exceeding the maximum daily doses. For example, products that contain too much acetaminophen could pose serious health risks, such as  liver damage. Signs of taking too much acetaminophen include nausea, vomiting, lethargy, sweating, loss of appetite and pain in the upper part of the abdomen or stomach. Abdominal pain may be the first sign of liver damage and may not be apparent for 24 to 48 hours. Risks of taking too much of an active ingredient may be higher for children and adolescents.

Health Canada identified these issues during an inspection. As a result, the company initiated a recall in September 2021 of certain powdered cold and flu medications. This recall is now being expanded after further investigation by the company identified additional affected products.

At Health Canada's direction, CellChem Pharmaceuticals Inc. has stopped selling and is recalling the affected products. Health Canada is monitoring the company's recall and the implementation of any corrective and preventative actions. If additional safety concerns are identified, Health Canada will take appropriate action and inform Canadians as needed.

Affected products

Product

Generic Store Brand

DIN

Extra Strength Total
Symptom Relief
Sugar-Free

  • Biomedic
  • Equate
  • Pharmasave
  • Wellness by London Drugs

02420937

Hot Lemon Relief for
Symptoms of Cold and
Flu (Extra strength)

 

  • Atoma
  • Biomedic
  • Life Brand
  • Option+
  • Personelle
  • Pharmasave
  • Rexall
  • Teva
  • Wellness by London Drugs
  • Western Family

02238890

Hot Lemon Relief for
Symptoms of Cold and
Flu (Regular strength)

 

  • Atoma
  • Life Brand
  • Personelle
  • Pharmasave
  • Rexall
  • Teva
  • Western Family

02047349

Hot Lemon Relief for
Symptoms of Cough,
Cold and Flu (Extra
Strength)

  • Life Brand

02246848

Night Time Total Extra
Strength

  • Life Brand

02344548

Total Flu

 

  • Atoma
  • Biomedic
  • Option+
  • Personelle
  • Pharmasave
  • Rexall

02442787

What you should do

Option+ Total Flu (CNW Group/Health Canada)

Biomedic Total Flu (CNW Group/Health Canada)

Atoma Total Flu (CNW Group/Health Canada)

Rexall Total Flu (CNW Group/Health Canada)

Life Brand Night Time Total Extra Strength (CNW Group/Health Canada)

Life Brand Hot Lemon Relief for Symptoms of Cough, Cold and Flu (Extra Strength) (CNW Group/Health Canada)

Biomedic Extra Strength Total Symptom Relief Sugar-Free (CNW Group/Health Canada)

Wellness by London Drugs Extra Strength Total Symptom Relief Sugar-Free (CNW Group/Health Canada)

Pharmasave Extra Strength Total Symptom Relief Sugar-Free (CNW Group/Health Canada)

Equate Extra Strength Total Symptom Relief Sugar-Free (CNW Group/Health Canada)

Biomedic Hot Lemon Relief for Symptoms of Cold and Flu (Extra strength) (CNW Group/Health Canada)

Life Brand Hot Lemon Relief for Symptoms of Cold and Flu (Extra strength) (CNW Group/Health Canada)

Atoma Hot Lemon Relief for Symptoms of Cold and Flu (Extra strength) (CNW Group/Health Canada)

Western Family Hot Lemon Relief for Symptoms of Cold and Flu (Extra strength) (CNW Group/Health Canada)

Wellness by London Drugs Hot Lemon Relief for Symptoms of Cold and Flu (Extra strength) (CNW Group/Health Canada)

Teva Hot Lemon Relief for Symptoms of Cold and Flu (Extra strength) (CNW Group/Health Canada)

Rexall Hot Lemon Relief for Symptoms of Cold and Flu (Extra strength) (CNW Group/Health Canada)

Pharmasave Hot Lemon Relief for Symptoms of Cold and Flu (Regular strength) (CNW Group/Health Canada)

Personelle Hot Lemon Relief for Symptoms of Cold and Flu (Regular strength) (CNW Group/Health Canada)

Life Brand Hot Lemon Relief for Symptoms of Cold and Flu (Regular strength) (CNW Group/Health Canada)

Atoma Hot Lemon Relief for Symptoms of Cold and Flu (Regular strength) (CNW Group/Health Canada)

Western Family Hot Lemon Relief for Symptoms of Cold and Flu (Regular strength) (CNW Group/Health Canada)

Teva Hot Lemon Relief for Symptoms of Cold and Flu (Regular strength) (CNW Group/Health Canada)

Rexall Hot Lemon Relief for Symptoms of Cold and Flu (Regular strength) (CNW Group/Health Canada)

Personelle Hot Lemon Relief for Symptoms of Cold and Flu (Extra strength) (CNW Group/Health Canada)

Option+ Hot Lemon Relief for Symptoms of Cold and Flu (Extra strength) (CNW Group/Health Canada)

Life Brand Hot Lemon Relief for Symptoms of Cold and Flu (Extra strength) (CNW Group/Health Canada)

Pharmasave Total Flu (CNW Group/Health Canada)

Personelle Total Flu (CNW Group/Health Canada)

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 06:03
The IAMStm brand, proudly part of the Mars family of brands, announced today the launch of the IAMStm Puppy Hub and Kitten Hub, two online tools featuring expert knowledge and advice for new and soon-to-be pet parents. Each Hub will bring...

at 06:00
Today, TELUS Health announced a collaboration with Nova Scotia Health (NSH) to enable residents of Nova Scotia to access their primary care information through the YourHealthNS app. This health data interoperability initiative marks the first...

at 05:30
The global Digital Healthcare Market, valued at $220.10 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $836.10 billion by 2031, growing at a compound annual growth rate (CAGR) of 21% from 2024 to...

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...



News published on and distributed by: